Periodontitis and Inflammation: Study on Biological Samples
NCT ID: NCT06012019
Last Updated: 2025-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2025-04-30
2028-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Neutrophils are the main cells of inflammation present within the periodontal pockets. The excess of certain neutrophils or the alteration of their functions is associated with the triggering of periodontitis, whereas their activity, finely orchestrated, would be a key to periodontal homeostasis. It is likely that some periodontal bacteria, including P. gingivalis, but also products of matrix catabolism could deregulate the physiological functions of neutrophils towards pro-inflammatory and catabolic profiles. Moreover, to date, the differentiation and role of neutrophil subsets in periodontal homeostasis as well as in gingivitis and its evolution into periodontitis remain poorly studied.
The investigators hypothesize that various subsets of neutrophils may play different roles during the development of periodontitis (evolution of gingivitis to periodontitis).
The primary objective is to characterize neutrophil subtypes associated with periodontal destruction during periodontitis.
Secondary objectives are :
1. Identify specific interactions of tissue-activated neutrophils with the matrix microenvironment during periodontitis
2. Identify specific interactions of tissue or oral (salivary) activated neutrophils with the oral microbiota during periodontitis
3. Identify specific oral (salivary) neutrophil subtypes in periodontal health, gingivitis and periodontitis
4. Evaluate the function, including pro-osteoclastogenic function, of oral neutrophils compared to blood neutrophils stimulated by infection
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periodontitis and Inflammation
NCT04831060
Immunoregulation of Periodontal Diseases
NCT02567019
Prevalence and Environmental Risk Indicators for Periodontitis. A Cross-sectional Study
NCT04771949
Immunoregulation of Periodontal Disease
NCT00702429
Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis
NCT01993368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be recruited in the oral medicine departments of AP-HP Charles Foix hospital (Ivry/seine) by periodontists in three groups (Cases : Group 1 : Gingivitis, Group 2 : Periodontitis, and Controls = healthy periodontium. All patients will require surgical care).
The time-line of the research is consistent with the usual patient management in oral medicine departments. Inclusion period is 36 months. There is no specific follow-up due to the research. Gingival tissue sampling during surgery of patients will be performed after their inclusion.
Assessment Criteria :
1. Neutrophil subtypes analysis based on co-expression of neutrophil function markers from a panel of 24 markers by imaging on sections.
2. Identification by immunohistofluorescence (on tissues) of the expression of matrix proteins described as regulating neutrophil function, and search of co-location between these proteins and certain neutrophil subtypes.
3. Identification by immunohistofluorescence (on tissue) of key bacteria of oral dysbiosis in periodontitis, and search for co-localization between these bacteria and certain neutrophil subtypes.
4. Assessment of neutrophil sub-types present in the patient's saliva and study of the correlation within tissue neutrophils during periodontal health, gingivitis and periodontitis.
5. Differentiation and activity of osteoclasts in co-culture with isolated oral /blood neutrophils in patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Periodontitis Cases
Patients with stage 3 or 4 periodontitis (Chicago 2017) ; BOP ≥ 10%, PD≥ 4mm Patients requiring surgical care such as dental avulsion or pre-prosthetic periodontal surgeries
Biological sampling in Periodontitis Case
Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;
J+7 : tooth extraction : gingival explant sampling
J+15 : Healing control
Gingivitis Cases
BOP ≥ 10%, PD≤ 3mm according to Chicago 2017 Patients requiring surgical care such as dental avulsion or pre-prosthetic periodontal surgeries
Biological sampling in Gingivitis Case
Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;
J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling
J+15 : Healing control
Control
BOP \< 10%, PD≤ 3mm Patients with gingival health on intact or reduced periodontium without a history of periodontitis and requiring surgical care such as dental avulsion or aesthetic surgeries
Biological sampling in Control Case
Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;
J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling
J+15 : Healing control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biological sampling in Periodontitis Case
Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;
J+7 : tooth extraction : gingival explant sampling
J+15 : Healing control
Biological sampling in Gingivitis Case
Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;
J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling
J+15 : Healing control
Biological sampling in Control Case
Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;
J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling
J+15 : Healing control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient \> 18 years old
* Patient affiliated to a national health insurance
* Patient who speaks and understands French well enough to be able to read and understand the study information note.
* Patient who does not object to his participation in the study
Specific Criteria :
* Control Group = BOP \< 10%, PI\<20%, PD≤ 3mm
* Gingivitis cases = BOP ≥ 10%, PD≤ 3mm
* Periodontitis cases = BOP ≥ 10%, PD\> 3mm
Exclusion Criteria
* Pregnant or breastfeeding women
* Patients suffering from a disease with defective neutrophil number, activity, activation or function
* Patient deprived of liberty by judicial or administrative decision.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marjolaine Gosset, PU-PH
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charles-Foix Hospital
Ivry-sur-Seine, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP230385
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.